Charles Schwab’s Ultralife ULBI Stock Holding History
Bought
Maintained
Sold
Other funds holding ULBI
VWA
THC
EIM
RC
Charles Schwab's ULBI Position: Q2 2025 in Review
Charles Schwab sold out of Ultralife (ULBI) in Q2 2025, closing a stake of 30,387 shares — an estimated $163K sold.
Charles Schwab first reported a position in ULBI in Q2 2020 and held it in 8 quarters. The position peaked at $323K in Q2 2024. 63 funds tracked by Wall St. Rank hold ULBI as of Q2 2025.
- Charles Schwab reported no remaining Ultralife position as of Q2 2025 after selling out during the quarter.
- Charles Schwab sold 30,387 Ultralife shares in Q2 2025, an estimated $163K.
- Charles Schwab first reported a position in Ultralife in Q2 2020 and held it in 8 quarters.
- Charles Schwab's Ultralife position peaked at $323K in Q2 2024.
- 63 funds tracked by Wall St. Rank held Ultralife as of Q2 2025.
Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.